当前位置: X-MOL 学术Acta Neuropathol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials.
Acta Neuropathologica ( IF 12.7 ) Pub Date : 2019-12-21 , DOI: 10.1007/s00401-019-02115-8
Anthony P Y Liu 1 , Brian Gudenas 2 , Tong Lin 3 , Brent A Orr 4 , Paul Klimo 5, 6, 7 , Rahul Kumar 2 , Eric Bouffet 8 , Sridharan Gururangan 9 , John R Crawford 10 , Stewart J Kellie 11 , Murali Chintagumpala 12 , Michael J Fisher 13 , Daniel C Bowers 14 , Tim Hassall 15 , Daniel J Indelicato 16 , Arzu Onar-Thomas 3 , David W Ellison 4 , Frederick A Boop 5, 6, 7 , Thomas E Merchant 17 , Giles W Robinson 1 , Paul A Northcott 2 , Amar Gajjar 1
Affiliation  

The original version of this article unfortunately contained a typesetting error in Fig 3c. The corrected Fig. 3 is given in the following page.

中文翻译:

校正至:血管母细胞瘤中风险适应性治疗和生物学异质性:来自前瞻性,多中心SJMB03和SJYC07试验的综合临床病理分析。

不幸的是,本文的原始版本在图3c中包含排版错误。下页给出了校正后的图3。
更新日期:2019-12-21
down
wechat
bug